semaglutide and armour thyroid Ozempic: EU Sees No Evidence That GLP-1 Drugs Cause Cancer T3, Armour, Naturethroid Thyroid Management

Laboratory investigations demonstrate that GHK-Cu application in experimental tissue models can reverse many of these age-related changes through direct effects on dermal architecture and cellular function

Several studies found that GLP-1RAs might have direct effects on adipogenesis, lipotoxicity, fatty acid oxidation, cytokines related to hepatitis and fibrosis, and intestinal microbiota (193, 195)

The timeline for achieving therapeutic goals with GLP-1 injections follows a predictable pattern, though individual responses vary

Clinical trials showed significant weight loss: Average of 15-20% body weight with many losing more

For offlabel uses, the evidence is preliminary and inconclusive